Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Estimated Enrollment: 238
Study Start Date: April 2008
Study Completion Date: July 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)

Estimated Enrollment: 238

But Lymphoseek turned out to be SO ACCURATE that they only need 129 patients to complete the study ? WOW !

NEOP recently tells us:

""""""The completed study evaluated 129 procedure compliant patients who had a total of 214 vital blue dye positive lymph nodes confirmed."""""

It looks like they were WAY OVER on the enrollment estimate, since they based that estimate on the miserable performance of the old sulphur colloid and Blue Dye .

We know they enrolled 130 patients . This we know because the CEO told us . And only 129 were procedure compliant because one patient had the wrong kind of cancer (bilateral disease).

So Lymphoseek was so accurate they only needed 129 patients to reach their goal of allowed Sentinel Nodes !

This is OUTSTANDING NEWS for cancer patients !

Gee, and the price is climbing from the .56 where it started the year .

$1.12 now. That's a DOUBLE ! WOW !

We know they enrolled 130 patients. This we know !

Can NEOP tell us what happened for Lymphoseek to have exceeded their expectations so much ?